Home > Riviste > Minerva Gastroenterology > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2014 June;60(2) > Minerva Gastroenterologica e Dietologica 2014 June;60(2):135-49

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Share

 

REVIEW   

Minerva Gastroenterologica e Dietologica 2014 June;60(2):135-49

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

Technical tips and issues of biliary stenting, focusing on malignant hilar obstruction

Lee T. H., Lee S. J., Moon J. H., Park S. H.

Division of Gastroenterology, Department of Internal Medicine, Soonchunhyang University School of Medicine, Cheonan Hospital, Cheonan and Bucheon Hospital, Bucheon, Republic of Korea


PDF


In patients with inoperable hilar cholangiocarcinoma (HCCA), palliative endoscopic or percutaneous drainage provides benefits in terms of symptomatic improvement and quality of life. Endoscopic biliary stent placement is considered the gold standard, with metal stents preferred over plastic stents in patients with more than three months of life expectancy. However, the endoscopic management of advanced hilar obstruction is often more challenging and complex than distal malignant biliary obstructions. Recently, the Asia-Pacific working group on hepatobiliary cancers produced consensus recommendations on the use of endoscopic vs. percutaneous drainage and unilateral vs. bilateral drainage in the management of HCCA. However, these guidelines must be weighed against context-specific information, such as the volume of liver drainage required, life expectancy of the patient, and the available expertise. In this literature review, we describe the issues commonly encountered during endoscopic biliary stenting for malignant hilar obstruction and provide technical guidance to improve success rates and patient outcomes.

inizio pagina